AGP Executive Report
Last update: 5 hours agoNeuro-ophthalmology R&D: Oculis says its Privosegtor neuroprotection program is advancing after positive FDA pre-IND feedback for acute multiple sclerosis relapses, while its dry eye trial (Licaminlimab) is progressing with sites activated and over 45% randomized. Local health policy pressure: Landsbankinn expects Iceland’s Central Bank to lift rates on August 19 as inflation stays stubbornly above target, with wage-agreement review risk if August inflation tops 4.7%. Food biosecurity at the border: Iceland’s Food and Veterinary Authority (MAST) tightens rules on what travellers can bring in, including a zero-tolerance approach to unlabelled or unpacked food that customs can confiscate and destroy. Nutrition research: A pan-Nordic trial reports a Nordic diet improved blood sugar and cholesterol markers even without weight loss, including results involving researchers from Iceland and neighbours. Wellness travel angle: A study ranks Iceland among Europe’s best digital nomad destinations in 2026, citing very fast internet and strong coworking access despite higher costs. Eye-safety reminder: Health experts warn against using ordinary sunglasses for the upcoming solar eclipse; proper eclipse glasses or safe viewing methods are needed.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.